These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 16935018

  • 1. Cascade of levodopa dose and weight-related dyskinesia in Parkinson's disease (LD-WD-PD cascade).
    Sharma JC, Macnamara L, Hasoon M, Vassallo M, Ross I.
    Parkinsonism Relat Disord; 2006 Dec; 12(8):499-505. PubMed ID: 16935018
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
    Kumar N, Van Gerpen JA, Bower JH, Ahlskog JE.
    Mov Disord; 2005 Mar; 20(3):342-4. PubMed ID: 15580606
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease.
    Fox S, Silverdale M, Kellett M, Davies R, Steiger M, Fletcher N, Crossman A, Brotchie J.
    Mov Disord; 2004 May; 19(5):554-60. PubMed ID: 15133820
    [Abstract] [Full Text] [Related]

  • 8. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R, Baker WL, Patel AA, Reinhart K, Coleman CI.
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [Abstract] [Full Text] [Related]

  • 9. Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease.
    Watts RL, Lyons KE, Pahwa R, Sethi K, Stern M, Hauser RA, Olanow W, Gray AM, Adams B, Earl NL, 228 Study Investigators.
    Mov Disord; 2010 May 15; 25(7):858-66. PubMed ID: 20461803
    [Abstract] [Full Text] [Related]

  • 10. Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson's disease.
    Arabia G, Zappia M, Bosco D, Crescibene L, Bagalà A, Bastone L, Caracciolo M, Scornaienghi M, Quattrone A.
    Neurol Sci; 2002 Sep 15; 23 Suppl 2():S53-4. PubMed ID: 12548340
    [Abstract] [Full Text] [Related]

  • 11. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R.
    Brain; 2006 Apr 15; 129(Pt 4):1059-69. PubMed ID: 16476674
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
    Zesiewicz TA, Sullivan KL, Maldonado JL, Tatum WO, Hauser RA.
    Mov Disord; 2005 Sep 15; 20(9):1205-9. PubMed ID: 15954135
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease.
    Strong JA, Dalvi A, Revilla FJ, Sahay A, Samaha FJ, Welge JA, Gong J, Gartner M, Yue X, Yu L.
    Mov Disord; 2006 May 15; 21(5):654-9. PubMed ID: 16435402
    [Abstract] [Full Text] [Related]

  • 18. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
    Kum WF, Gao J, Durairajan SS, Man SC, Xie LX, Lu JH, Fong WL, Li M.
    J Clin Neurosci; 2009 Aug 15; 16(8):1034-7. PubMed ID: 19428256
    [Abstract] [Full Text] [Related]

  • 19. Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study.
    Zappia M, Annesi G, Nicoletti G, Arabia G, Annesi F, Messina D, Pugliese P, Spadafora P, Tarantino P, Carrideo S, Civitelli D, De Marco EV, Cirò-Candiano IC, Gambardella A, Quattrone A.
    Arch Neurol; 2005 Apr 15; 62(4):601-5. PubMed ID: 15824260
    [Abstract] [Full Text] [Related]

  • 20. Disordered respiration as a levodopa-induced dyskinesia in Parkinson's disease.
    Rice JE, Antic R, Thompson PD.
    Mov Disord; 2002 May 15; 17(3):524-7. PubMed ID: 12112201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.